SNDX Insider Holders & Insider Ownership - Syndax Pharmaceuticals Inc

List of insiders holdings for Syndax Pharmaceuticals Inc:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

#	Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
1	Domain Partners VI L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE 10% Owner	2016-03-08 11:47:21	1,743,854 0	1,743,854	Form 4
2	BVF PARTNERS L P BIOTECHNOLOGY VALUE FUND L P BIOTECHNOLOGY VALUE FUND II LP Biotechnology Value Trading Fund OS LP BVF Partners OS Ltd. BVF INC LAMPERT MARK N 10% Owner	2023-02-14 11:53:10	1,451,197 0	1,451,197	Form 13G
3	Domain Partners VIII L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner	2021-01-20 19:57:09	1,162,554 0	1,162,554	Form 13G
4	ROYSTON IVOR Director	2017-03-22 13:37:24	0 625,545	625,545	Form 4
5	Metzger Michael A Chief Executive Officer	2025-09-08 18:45:31	298,661 0	298,661	Form 4
6	Sabus Steve M Chief Commercial Officer	2022-12-05 16:41:39	220,000 0	220,000	Form 4
7	Podlesak Dennis Director	2025-08-18 17:02:20	191,763 0	191,763	Form 4
8	Shaw Allan Chief Financial Officer	2016-03-02 18:06:46	137,600 0	137,600	Form 3
9	Madigan Catherine Chief Medical Officer	2023-02-03 17:01:12	110,000 0	110,000	Form 4
10	Katkin Keith Director	2025-05-19 16:01:06	100,000 0	100,000	Form 4
11	Karydas Daphne Chief Financial Officer	2021-02-05 16:22:19	95,000 0	95,000	Form 4
12	Goldan Keith A. Chief Financial Officer	2025-08-07 17:30:22	94,902 0	94,902	Form 4
13	Meury William Director	2025-02-07 16:38:33	90,000 0	90,000	Form 4
14	Jarrett Jennifer Director	2025-02-07 16:35:56	90,000 0	90,000	Form 4
15	Legault Pierre Director	2025-02-07 16:32:17	90,000 0	90,000	Form 4
16	Gallagher Neil President, Head of R&D	2025-02-12 17:13:24	85,095 0	85,095	Form 4
17	Huber Martin H. Jr. Director	2025-05-19 16:02:03	79,000 0	79,000	Form 4
18	Shea Richard P Chief Financial Officer	2020-02-14 16:37:17	53,227 0	53,227	Form 4
19	Meyers Michael L. SVP, Chief Medical Officer	2022-02-03 17:31:53	42,344 0	42,344	Form 4
20	Botwood Nicholas A.J. Head of R&D, CMO	2025-05-19 16:03:03	35,165 0	35,165	Form 4
21	Morrison Briggs Director	2024-02-09 16:04:08	34,836 0	34,836	Form 4
22	Egros Fabrice Director	2022-02-03 17:29:44	32,000 0	32,000	Form 4
23	Rizo Aleksandra Director	2025-02-07 16:39:46	25,000 0	25,000	Form 4
24	Nolte Alexander Chief Accounting Officer	2023-02-03 16:58:24	17,000 0	17,000	Form 4
25	EVNIN LUKE Director 10% Owner	2018-05-25 09:00:11	14,000 0	14,000	Form 4
26	Chen Henry Director	2018-05-25 09:00:25	14,000 0	14,000	Form 4
27	DP VI Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Director 10% Owner	2016-03-08 11:52:26	13,925 0	13,925	Form 4
28	DOMAIN ASSOCIATES BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K Kamdar Kim P. Shah Nimesh 10% Owner	2016-03-02 18:37:27	13,564 0	13,564	Form 3
29	Kamdar Kim P. Director 10% Owner	2016-11-02 16:44:50	8,000 0	8,000	Form 4
30	DP VIII Associates L.P. BLAIR JAMES C DOVEY BRIAN H TREU JESSE I VITULLO NICOLE Halak Brian K 10% Owner	2016-03-08 11:41:42	5,641 0	5,641	Form 4
31	Sledge George W. Jr. Director	2017-05-19 11:27:01	5,000 0	5,000	Form 4
32	Ordentlich Peter Chief Scientific Officer	2023-02-17 18:09:58	0 0	0	Form 4
33	MPM BioVentures IV QP LP Scopa James Paul Foley Todd GADICKE ANSBERT KAILIAN VAUGHN M MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. 10% Owner	2021-02-12 16:06:57	0 0	0	Form 13G

Insider Holders & Insider Ownership - Syndax Pharmaceuticals Inc (SNDX)